|
Code
|
6172E
|
|
MA number
|
16/0109/24-S
|
|
Product Form:
|
plv fol 1x500 U+5 ml solv. (liek.inj.skl.+prísl.+Baxject II Hi-Flow)
|
|
MA Status:
|
R - Valid Marketing Authorisation
|
|
Type of procedure:
|
Decentralised
|
|
MAH, country:
|
Baxalta Innovations GmbH, Austria
|
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
|
ATC:
|
| B |
BLOOD AND BLOOD FORMING ORGANS |
| B02 |
ANTIHEMORRHAGICS |
| B02B |
LOCAL HEMOSTATICS, COMBINATIONS |
| B02BD |
Blood coagulation factors |
| B02BD03 |
Factor VIII inhibitor bypassing activity |
|
|
Shelf life:
|
24 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Intravenous use
|
PIL_FEIBA 100 U ml_05.2024.pdf
